{"id":123011,"date":"2021-11-16T14:08:18","date_gmt":"2021-11-16T14:08:18","guid":{"rendered":"https:\/\/fin2me.com\/?p=123011"},"modified":"2021-11-16T14:08:18","modified_gmt":"2021-11-16T14:08:18","slug":"cathie-woods-ark-invest-buys-nearly-825000-shares-of-butterfly-network","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/cathie-woods-ark-invest-buys-nearly-825000-shares-of-butterfly-network\/","title":{"rendered":"Cathie Wood’s ARK Invest Buys Nearly 825,000 Shares of Butterfly Network"},"content":{"rendered":"
One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought about 825,000 shares of Butterfly Network Inc. (NYSE: BFLY) on Monday. The share price of this ETF was down over 2% in Monday\u2019s session, and the fund is actually the only ARK Invest fund with a loss year over year.<\/p>\n
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 824,841 shares of this ultrasound imagining device maker. At Monday\u2019s closing price, this would have valued this purchase at roughly $6.2 million. This is only a small fraction of the total holdings. The ETF is down about 2% in the past year.<\/p>\n
Check out all of ARK Invest\u2019s buys for Monday:<\/p>\n
Fund<\/th>\n | Ticker<\/th>\n | Name<\/th>\n | Shares<\/th>\n<\/tr>\n<\/thead>\n |
---|---|---|---|
ARKF<\/td>\n | DKNG<\/td>\n | DRAFTKINGS<\/td>\n | 214,059<\/td>\n<\/tr>\n |
ARKF<\/td>\n | TWLO<\/td>\n | TWILIO<\/td>\n | 17,600<\/td>\n<\/tr>\n |
ARKF<\/td>\n | TOST<\/td>\n | TOAST<\/td>\n | 87,242<\/td>\n<\/tr>\n |
ARKF<\/td>\n | PAGS<\/td>\n | PAGSEGURO DIGITAL<\/td>\n | 47,218<\/td>\n<\/tr>\n |
ARKF<\/td>\n | HOOD<\/td>\n | ROBINHOOD MARKETS<\/td>\n | 296,385<\/td>\n<\/tr>\n |
ARKG<\/td>\n | QSI<\/td>\n | QUANTUM-SI<\/td>\n | 115,300<\/td>\n<\/tr>\n |
ARKG<\/td>\n | ONEM<\/td>\n | 1LIFE HEALTHCARE<\/td>\n | 108,326<\/td>\n<\/tr>\n |
ARKG<\/td>\n | VERV<\/td>\n | VERVE THERAPEUTICS<\/td>\n | 43,580<\/td>\n<\/tr>\n |
ARKG<\/td>\n | BFLY<\/td>\n | BUTTERFLY NETWORK<\/td>\n | 824,841<\/td>\n<\/tr>\n |
ARKG<\/td>\n | ALLO<\/td>\n | ALLOGENE THERAPEUTICS<\/td>\n | 114,528<\/td>\n<\/tr>\n |
ARKG<\/td>\n | SGFY<\/td>\n | SIGNIFY HEALTH<\/td>\n | 159,698<\/td>\n<\/tr>\n |
ARKK<\/td>\n | VCYT<\/td>\n | VERACYTE<\/td>\n | 63,300<\/td>\n<\/tr>\n |
ARKK<\/td>\n | TWOU<\/td>\n | 2U<\/td>\n | 118,996<\/td>\n<\/tr>\n |
ARKK<\/td>\n | NTLA<\/td>\n | INTELLIA THERAPEUTICS<\/td>\n | 112,914<\/td>\n<\/tr>\n |
ARKK<\/td>\n | MTLS<\/td>\n | MATERIALISE<\/td>\n | 27,228<\/td>\n<\/tr>\n |
ARKK<\/td>\n | BEAM<\/td>\n | BEAM THERAPEUTICS<\/td>\n | 32,531<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | ACHR<\/td>\n | ARCHER AVIATION<\/td>\n | 304,243<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | VLD<\/td>\n | VELO3D<\/td>\n | 33,680<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | TSP<\/td>\n | TUSIMPLE<\/td>\n | 91,200<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | PRLB<\/td>\n | PROTO LABS<\/td>\n | 163,115<\/td>\n<\/tr>\n |
ARKW<\/td>\n | ZM<\/td>\n | ZOOM VIDEO COMMUNICATIONS<\/td>\n | 30,800<\/td>\n<\/tr>\n |
ARKW<\/td>\n | SPLK<\/td>\n | SPLUNK<\/td>\n | 119,677<\/td>\n<\/tr>\n |
ARKW<\/td>\n | DIS<\/td>\n | WALT DISNEY<\/td>\n | 86,340<\/td>\n<\/tr>\n |
ARKX<\/td>\n | DDD<\/td>\n | 3D SYSTEMS<\/td>\n | 43,040<\/td>\n<\/tr>\n |
ARKX<\/td>\n | GRMN<\/td>\n | GARMIN<\/td>\n | 7,820<\/td>\n<\/tr>\n |
ARKX<\/td>\n | MKFG<\/td>\n | MARKFORGED<\/td>\n | 27,381<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24\/7 Wall St., owner of 247wallst.com.\n\t\t<\/p>\n |